Small intestinal bacterial overgrowth (SIBO) is still labeled a “GI diagnosis,” but your SIBO patients live in endocrine, allergy, rheum, and primary care clinics as well as yours.
This first article in the Beyond the Gut series is written for you as a gastroenterologist. The goal is simple: show how hypothyroidism links to SIBO, why that matters for your workups, and why a coordinated approach with endocrinology makes sense.
What recent data show
Cedars-Sinai investigators reported in the Journal of Clinical Endocrinology & Metabolism that:
- Patients with hypothyroidism had a higher risk of SIBO than euthyroid controls.
- Risk was higher with autoimmune thyroid disease.
- Treated patients on levothyroxine had lower SIBO risk than untreated patients.
The signal is consistent with what many GIs already see in clinic. A subset of hypothyroid patients with “IBS” symptoms, recurrent bloating, or treatment resistant SIBO.
Why this makes sense for you
Three points matter for GI practice.
Motility
- Thyroid hormone affects gut motility.
- Hypothyroidism slows gastric emptying and small bowel transit.
- Slower transit increases residence time in the small bowel, which favors overgrowth.
Autoimmunity and barrier function
- Autoimmune thyroid disease involves broader immune activation.
- That state affects mucosal immunity and barrier integrity in the small intestine.
- Altered barrier function and immune tone support dysbiosis and recurrent SIBO.
Hormone replacement
- Patients on levothyroxine in the Cedars-Sinai cohort had lower SIBO risk.
- Better hormone replacement improves motility and metabolic tone.
- That supports the idea that endocrine optimization and SIBO control support each other.
For you, this means hypothyroidism is not a side note in the history. It is part of the SIBO risk profile.
How to factor hypothyroidism into your SIBO workups
You already see bloating, pain, and stool changes all day. The question is when thyroid disease should change your threshold for testing and your follow up strategy.
Consider SIBO testing or retreatment more strongly when you see:
- Documented hypothyroidism or autoimmune thyroid disease plus chronic bloating, pain, or altered stool that predates or outlasts endocrine treatment.
- A history of fluctuating thyroid control with parallel GI symptom swings.
- Partial or short lived response to prior SIBO therapy in a hypothyroid patient.
- SIBO breath tests that are positive with no obvious structural or surgical driver, but with known thyroid disease.
When you confirm SIBO in a hypothyroid patient:
- Communicate the result to endocrinology.
- Ask whether thyroid control is stable and whether dose adjustments are in progress.
- Flag recurrent SIBO in poorly controlled hypothyroidism as a joint problem to solve.
How to talk about this link with endocrinology
Endocrinologists will care about this connection if you keep the message practical.
You can anchor your conversation in three points:
- Hypothyroidism increases SIBO risk through slower motility and immune shifts.
- Treated patients on levothyroxine in the Cedars-Sinai study had lower SIBO risk, which supports the role of good endocrine control.
- Recurrent or severe bloating, pain, or bowel changes in “optimized” hypothyroid patients deserve joint review.
Suggested talking points for a referral note or curbside:
- “This patient has confirmed SIBO and a history of autoimmune hypothyroidism. Transit and immune factors linked to thyroid status likely contribute to the overgrowth picture.”
- “GI symptoms remain significant despite current thyroid control on labs. A check on dosing, absorption, and stability would help reduce recurrence risk.”
- “If thyroid status has been unstable, SIBO control will be harder. A shared plan around timing of GI and endocrine adjustments would be useful.”
Why a multidisciplinary view helps you
For SIBO, hypothyroidism is one of several non GI conditions that change pretest probability and recurrence risk. Others include chronic urticaria, asthma and food allergy, scleroderma, and neurologic disease.
If you treat SIBO in isolation, you will see:
- Higher relapse rates in patients whose underlying motility or immune drivers are not addressed.
- Frustrated patients who feel they move between “GI” and “thyroid” clinics without a joined up plan.
- More repeat testing and retreatment than necessary.
If you integrate endocrine context into your SIBO thinking, you gain:
- Clearer risk stratification at the time of ordering breath tests.
- More realistic expectations for patients with autoimmune thyroid disease, especially around recurrence.
- Stronger relationships with referring endocrinologists who see that GI is thinking beyond the lumen.
Key points for your next clinic
When you see your next SIBO or “IBS” patient with thyroid disease, you can ask yourself:
- Is thyroid disease autoimmune, under treated, or unstable
- Do GI symptoms line up with thyroid history or persist despite biochemical control
- Should I check for SIBO now, or is this a case to watch after better thyroid optimization
- If breath testing is positive, who on the endocrine side should see this result and adjust the plan with me
This is the role of Beyond the Gut for GIs. Not to turn you into an endocrinologist, but to ensure your SIBO decisions account for the rest of the patient’s story, and to give you simple entry points for multidisciplinary care.
